TABLE 1.
Effects of single- and double-point alanine mutagenesis of aromatic residues in the upper part of P2XR-TM1 domains on receptor functions.
P2XRs | ATP EC50 (µM) |
ATP Imax (nA) |
ATP τoff (s) |
αβ–meATP EC50 (µM) |
αβ–meATP efficacy (%)a |
---|---|---|---|---|---|
P2X2R-WT | 5.4±0.8 | 2.6±0.2 | 0.34±0.05 | >100 | 44 |
P2X2R-F49A | 10.8±2.1* | 2.2±0.2 | 0.44±0.06 | >100 | 32 |
P2X2R-Y47A | 0.82±0.1* | 0.46±0.1* | 0.36±0.02 | 11.8±2* | 83 |
P2X2R-F44A | 0.26±0.05* | 0.44±0,1* | 1±0.07* | 3.4±1* | 95 |
P2X2R-Y43A | 0.28±0.05* | 0.80±0.1* | 1.3±0.1* | 8.2±1* | 94 |
P2X2R-Y43F | 8.2±1.8 | 2.8±0.4 | 0.47±0.1 | >100 | 65 |
P2X3R-WT | 0.35±0.12 | 1.6±0.2 | 0.55±0.05 | 0.59±0.1 | 100 |
P2X3R-F43A | 0.35±0.2 | 0.9±0.1* | 0.75±0.06 | 0.32±0.2 | 100 |
P2X3R-W41A | 0,39±0.15 | 0.7±0.07* | 0.67+±0.08 | 0,56±15 | 100 |
P2X3R-F38A | 0.31±0.2 | 0.3±0.05* | 1.95±0.27* | 0.29±0,05 | 100 |
P2X3R-Y37A | 0.14±0.1* | 1.2±0.2 | 0.60±0.01 34.±2*b |
0.27±0.1 | 100 |
P2X4R-WT | 4.6±0.3 | 1.6±0.2 | 0.42±0.03 | 57±9 | 42 |
P2X4R-W50A | 5.1±1.3 | 1.7±0.2 | 0.35±0.08 | 85±15 | 24 |
P2X4R-F48A | 4.1±0.5 | 1.5±0.8 | 0.6±0.04 | 13.4±2.1* | 62 |
P2X4R-W46A | 3.0±0.5 | 1.0±0.16 | 0.6±0.1 | 8.9±1.6* | 73 |
P2X4R-Y42A | 0.6±0.1* | 0.6±0.3* | 24±2.9* | 0.6±0.05* | 100 |
P2X4R-42A+V43A | 0.9±0.1* | 0.3±0.03* | 49±2.6* | 0.9±0.3* | 100 |
P2X4R-42A+W46A | 1.4±0.2* | 1.4±0.3 | 1.2±0.05* | 4.7±2.0* | 44 |
P2X4R-42A+F48A | 0.3±0.1* | 0.2±0.03* | 54±5* | 0.3±0.1* | 100 |
P2X4R-42A+W50A | 1.6±0.3* | 1.2±0.4 | 1.6±0.2* | 8.3±2.3* | 53 |
P2X4R-Y42A+I39A | n.d. | 0.1±0.05* | n.d. | n.d. | n.d. |
P2X4R-42A+V35A | 0.6±0.1* | 0.4±0.1* | 33±4.4* | 0.6±0.2* | 100 |
P2X4R-42A+G29A | 0.4±0.1* | 0.5±0.1* | 34±3.4* | 0.4±0.05* | 77 |
Data shown are mean±SEM values derived from 5 to 35 cells.
P<0.01 between WT and mutants
αβ-me ATP efficacy was calculated as ratio of Imax at 300 µM αβ-meATP/Imax at 100 µM ATP
deactivation kinetics of this mutant was biexponential and τoff2 value for slow deactivation component contributed with 36±4 % to the current decay.